Friday, December 9, 2011

New for DDP 2012 - Speakers, Companies, Tracks and Topics Never Heard Before!

Are you tired of hearing the same old speakers talk about new innovations that are arguably not new, nor innovative? At DDP this year you’ll hear over 80 speakers divulge of-the-moment strategies, brand new case studies, and lessons learned that will help you move your drug delivery programs forward because we know nothing is more valuable than hearing pharmaceutical executives share how they utilize drug delivery to improve effectiveness and patient compliance.

At DDP, over 50% of our speakers are new to the event. Never before at DDP have you heard from:
  • • Christopher Seaton, Senior Vice President, Global Licensing, Bayer Pharmaceuticals
  • • John Baldoni, Senior Vice President, Platform Technology & Science, GlaxoSmithKline Pharmaceuticals R&D
  • • Uros Urleb, Chief Scientific Officer, Sandoz International GmbH
  • • Ronald Smith, PhD, Executive Director and Head Product Value Enhancements, Merck & Co
  • • Paul Gellert, Senior Principal Scientist, Astrazeneca
  • • Michael Kaufman, Vice President, Pharmaceutical Sciences, Millennium Pharmaceuticals
  • • Joel Richard, Vice President, Drug Product Development, Ipsen
For more information on these new speakers to 2012 and the rest of the program, download the brochure.

Drug Delivery Partnerships is taking place January 25-27, 2012. As a member of the Drug Delivery Partnerships International LinkedIn Group, you get a 25% discount off the standard rate when using code XP1778BLOG. If you have any questions about the agenda or event, please contact Jennifer Pereira at or visit our webpage.

No comments:

Post a Comment